| Dr Joy A Kassett, PHD | |
|
6416 31st Pl Nw, Washington, DC 20015-2350 | |
| (202) 237-1793 | |
| Not Available |
| Full Name | Dr Joy A Kassett |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 6416 31st Pl Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174847784 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joy A Kassett, PHD 6416 31st Pl Nw, Washington, DC 20015-2350 Ph: (202) 237-1793 | Dr Joy A Kassett, PHD 6416 31st Pl Nw, Washington, DC 20015-2350 Ph: (202) 237-1793 |
News Archive
Inform Genomics, Inc., a private company focused on developing novel platforms of personalized medicine products for cancer supportive care and inflammatory diseases, today announced the completion of the first phase of product development to predict a patient's risk of developing oral mucositis after receiving high dose chemotherapy prior to hematopoietic stem cell transplant.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
Special efforts should be made to identify and treat depression and urinary incontinence in postmenopausal women with vaginal symptoms, according to UC San Francisco researchers, as these two common conditions not only tend to co-exist with vaginal symptoms but also may complicate the impact of these symptoms on women's daily activities and quality of life.
Using stem cells to restore lost functions due to spinal cord injury (SCI) has long been an ambition of scientists and doctors.
Ortho Biotech Products, L.P. has announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL (doxorubicin HCI liposome injection) for the treatment of women with relapsed ovarian cancer (ROC).
› Verified 6 days ago
Dr. Leila Bremer, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1330 New Hampshire Ave Nw, Suite 106, Washington, DC 20036 Phone: 202-887-0404 | |
Dr. Chester Wayne Bullock Jr., PSYD, MED Psychologist Medicare: Not Enrolled in Medicare Practice Location: 910 17th St Nw Ste 419, Washington, DC 20006 Phone: 202-505-2795 | |
Dr. Megan Laabs, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 202-782-8671 | |
Dana Footer, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Dr. Jennifer Lee Bakalar, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2000 P St Nw Ste 408, Washington, DC 20036 Phone: 202-932-0893 | |
Dr. Karin Leah Arndt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4601 Connecticut Ave Nw, Suite 20, Washington, DC 20008 Phone: 716-239-0723 | |
Renee Michelle Neely-walters, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5800 8th St Nw, Washington, DC 20011 Phone: 202-541-6608 |